Skip to main content
. 2022 Apr 5;4(6):100483. doi: 10.1016/j.jhepr.2022.100483

Table 1.

Baseline characteristics based on alpha-1 antitrypsin genotype.

Trait Pi∗MM, n = 474 Pi∗MZ, n = 49 Pi∗MS, n = 52 p value
Age (years) 58.1 (51.1-65.0) 59.5 (43.9-66.2) 57.8 (50.1-67.0) 0.99
Male 59.5% 49.0% 52.9% 0.20
Hypertension 70.3% 65.3% 80.4% 0.58
Hyperlipidemia 47.9% 53.1% 56.9% 0.59
Diabetes 53.6% 63.3% 47.1% 0.25
Coronary artery disease 25.3% 25.0% 22.0% 1.0
Cerebrovascular disease 6.2% 4.2% 6.0% 0.80
Body mass index (kg/m2) 31.4 (26.4-36.9) 30.7 (27.3-38.5) 31.6 (27.5-36.1) 0.69
Smoking history
 Never 41.4% 44.9% 37.3% 0.31
 Former 36.3% 44.9% 39.2%
 Current 22.4% 10.2% 23.5%
Illicit drug use history 14.5% 8.3% 3.9% 0.34
Cirrhosis etiology
 Non-alcoholic fatty liver disease or cryptogenic 44.1% 40.8% 54.9% 0.15
 Hepatitis C alone 15.3% 10.4% 13.7%
 Alcohol alone 18.1% 16.3% 15.7%
 Hepatitis C and alcohol 9.4% 4.2% 9.8%
 Other 13.7% 28.6% 5.9%
Gastroesophageal varices 47.0% 42.6% 46.0% 0.67
Clinically significant portal hypertension
48.5%
46.8%
46.0%
0.92
Laboratory values
 Creatinine (mg/dl) 0.9 (0.7-1.1) 0.8 (0.7-1.0) 0.9 (0.8-1.1) 0.36
 Hemoglobin A1c (%) 6.1 (5.4-7.8) 7.1 (5.9-7.8) 5.8 (5.2-7.2) 0.13
 Alanine aminotransferase (U/L) 43.0 (26.0-73.0) 39.0 (28.0-57.0) 35.0 (23.0-51.5) 0.10
 Aspartate aminotransferase (U/L) 49.0 (33.0-79.5) 54.0 (41.0-71.0) 46.0 (28.0-78.5) 0.48
 Total bilirubin (mg/dl) 0.8 (0.5-1.5) 1.1 (0.7-2.0) 0.8 (0.5-1.5) 0.037
 Alkaline phosphatase (U/L) 119.0 (85.0-172.5) 124.0 (90.0-166.0) 109.0 (81.5-138.5) 0.39
 Albumin (mg/dl) 3.9 (3.4-4.3) 3.9 (2.9-4.2) 4.0 (3.5-4.3) 0.76
 Platelets (K/ul) 129.0 (97.0-194.8) 140.0 (105.0-198.0) 161.0 (97.5-238.0) 0.17
 Model for end-stage liver disease score 8.5 (7.2-11.9) 10.0 (7.7-13.1) 8.2 (7.2-13.8) 0.29

Three-way comparisons of continuous variables were performed with Kruskal-Wallis statistics, and comparisons of categorical variables were performed using a chi-squared statistic.